Newron Pharmaceuticals Spa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other
miscellaneous service companies in Europe:
of the United Kingdom
sales of £10.74 million [US$14.06 million]
of which 100%
was Medical Service),
of the Netherlands
(12.65 million Euro [US$14.76 million]
of which 99%
was Catalysis), and
based in France
(14.31 million Euro [US$16.69 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Newron Pharmaceuticals Spa were 13.29 million Euro (US$15.50 million).
increase of 180.5%
versus 2016, when the company's sales were 4.74 million Euro.
This was the third consecutive year of growth at Newron Pharmaceuticals Spa.